Cure for binge drinking? This endorphin-blocking pill could help people consume less alcohol

Credit: Hippopx
Credit: Hippopx

A medicine used to treat people with severe alcohol disorders could also be helpful for others against binge drinking, a study says.

The drug, naltrexone, blocks endorphins and reduces the feelings of happiness that come with drinking. It’s been approved for three decades to treat people with alcohol dependence and usually is given daily to patients with more severe alcohol disorders to help them choose not to drink, The New York Times reported.

Binge drinking means having more than four drinks in a sitting for men and more than three for women. Almost half of American drinkers say they’ve binged within the last month, the government says. Although only a low percentage of binge drinkers reportedly are dependent on drinking, it can still cause illness and injury and lead to a worse problem.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Study results could help lead to treatment before addiction – even for “far more people, like the study’s participants,” the paper said, such as those with mild or moderate alcohol disorders.

“If we attack the medical problem right away and early on, you cannot only treat the problem but prevent the development of the more severe forms of the disease,” said Lorenzo Leggio, MD, of the National Institutes of Health.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.